Tuesday, May 31, 2016

Healthcare Tips: Amicus' Fabry disease drug gets European Commission approval

(Reuters) - Amicus Therapeutics Inc said on Tuesday the European Commission approved its experimental treatment for Fabry disease.

Read more: Amicus' Fabry disease drug gets European Commission approval